Immuneering Corporation

NASDAQ: IMRX · Real-Time Price · USD
3.79
0.75 (24.67%)
At close: Aug 15, 2025, 3:59 PM
3.65
-3.57%
After-hours: Aug 15, 2025, 07:49 PM EDT

Immuneering Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-1.08 -3.91 -2.6 -12.69
PEG Ratio
-0.13 -7.3 -0.05 -15.99
PS Ratio
n/a n/a 403.77 204.62
PB Ratio
1.59 2.31 1.17 2.73
P/FCF Ratio
-1.2 -4.24 -2.85 -13.77
P/OCF Ratio
-1.2 -4.27 -2.9 -13.8
OCF/S Ratio
n/a n/a -139.14 -14.83
Debt / Equity Ratio
0.10 0.05 0.04 0.03
Quick Ratio
5.28 11.35 13.50 27.04
Current Ratio
5.28 11.35 13.50 27.04
Asset Turnover
n/a n/a 0.00 0.01
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-1.47 -0.59 -0.45 -0.22
Return on Assets
-1.16 -0.52 -0.4 -0.2
Return on Invested Capital
-1.41 -0.61 -0.44 -0.21
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a 0.50 0.45
Net Profit Margin
n/a n/a -155.49 -16.12
Pretax Profit Margin
n/a n/a -159.37 -16.27
Operating Profit Margin
n/a n/a -163.26 -16.29
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a -162.38 -16.19